Researchers advance therapeutic West Nile vaccine; autism linked to rainy days;

Vaccine Research

Researchers are developing a DNA-based vaccine against the dreaded West Nile virus, which can be transmitted from animals to humans. The unique feature of this vaccine is that it is also effective after onset of the disease, for it has therapeutic properties. Release

Researchers at the Moores Cancer Center at the University of California, San Diego are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia. Release

Integrated BioTherapeutics recently won a contract from the National Institute of Allergy and Infectious Diseases to do research on a new Ebola vaccine. Report

Cornell University researchers say that autism occurs more frequently among children living in rainy climates. Report

Vaccine market

A new predictive model shows that vaccinating infants with 7 valent pneumococcal conjugate vaccine--the current recommendation--not only saves lives and money during a normal flu season by preventing related bacterial infections; it also would prevent more than 357,000 deaths during an influenza pandemic, while saving $7 billion in costs. Release

Virogen has received purchase orders totaling $400,000 from its Asian and Middle Eastern distributors for its vaccine to combat Newcastle disease, a disease that kills chickens worldwide. Release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.